The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth

International Journal of Cancer

Volumn 132, Issue 11, 2013, Pages 2492-2501

  Jeong, Hyun Ja ^a   Oh, Hyun A ^b   Nam, Sun Young ^b   Han, Na Ra ^b   Kim, Young Sick ^b   Kim, Jeong Hwa ^c   Lee, Seok Jong ^d   Kim, Min Ho ^e   Moon, Phil Dong ^b   Kim, Hyung Min ^b  

^a Hoseo University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Ewha Womans University   (South Korea)

^d Kyungpook National University   (South Korea)

^e Chonbuk National University   (South Korea)

Author keywords

HIF 1 ; histamine; histamine receptor antagonist; mast cells; melanoma

Indexed keywords

CASPASE 3; CISPLATIN; HISTAMINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROMETHAZINE; TERFENADINE; TRYPTASE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CARCINOGENESIS; CELL MIGRATION; CONTROLLED STUDY; DRUG TARGETING; ENDOTHELIUM CELL; FIBROBLAST; HISTAMINE RELEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAST CELL; MELANOMA; NONHUMAN; OTOTOXICITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT OUTCOME; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BONE MARROW; CELL HYPOXIA; CELL PROLIFERATION; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTAMINE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOENZYME TECHNIQUES; MAST CELLS; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, HISTAMINE H1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; STROMAL CELLS; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875577954     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27937     Document Type: Article

References (40)

1. Jung JF, Scholz LT,. Mast cells: roles, interactions and disorders. New York: Nova Science Publishers, 2008. 157-179.
2. Pejler G, Rönnberg E, Waern I, Wernersson S,. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 2010; 115: 4981-4990.
3. Starkey JR, Crowle PK, Taubenberger S,. Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer 1988; 42: 48-52.
4. Yatsunami K, Ohtsu H, Tsuchikawa M, et al. Structure of the L-histidine decarboxylase gene. J Biol Chem 1994; 269: 1554-1559.
5. Ash ASF, Schild HO,. Receptors mediating some actions of histamine. Br J Pharmacol 1997; 120: 302-314.
6. 3) of histamine receptor. Nature 1983; 302: 832-837.
7. White MV,. The role of histamine in allergic disease. J Allergy Clin Immunol 1990; 86: 599-605.
8. Van Haaster CM, Engels W, Duijvestijn AM, Lemmens PJ, Hornstra G, Van der Vusse GJ,. Lack of evidence for a role of mast cell degranulation in acute hypoxia/reoxygenation-induced injury in the isolated rat heart. J Mol Cell Cardiol 1996; 28: 363-373.
9. Huang B, Lei Z, Zhang GM, et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008; 112: 1269-1279.
10. Wang GL, Semenza GL,. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 1993; 82: 3610-3605.
11. Yamashita K, Discher DJ, Hu J, et al. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J Biol Chem 2001; 276: 12645-12653.
12. Zarember KA, Malech HL,. HIF-1alpha: a master regulator of innate host defenses? J Clin Invest 2005; 115: 1702-1704.
13. Semenza GL, Roth PH, Fang HM, et al. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994; 269: 23757-23763.
14. Jeong HJ, Moon PD, Kim SJ, et al. Activation of hypoxia-inducible factor-1 regulates human histidine decarboxylase expression. Cell Mol Life Sci 2009; 66: 1309-1319.
15. Oh HA, Ryu JG, Cha WS, et al. Therapeutic effects of traditional Korean medicine, Jeechool-Whan in allergic rhinitis model. Tang 2012; 2: e9.
16. Jeong HJ, Chung HS, Lee BR, et al. Expression of proinflammatory cytokines via HIF-1alpha and NF-kappaB activation on desferrioxamine-stimulated HMC-1 cells. Biochem Biophys Res Commun 2003; 306: 805-811.
17. Walczak-Drzewiecka A, Ratajewski M, Wagner W, et al. HIF-1alpha is up-regulated in activated mast cells by a process that involves calcineurin and NFAT. J Immunol 2008; 181: 1665-1672.
18. Walczak-Drzewiecka A, Ratajewski M, Pułaski Ł, et al. DNA methylation-dependent suppression of HIF1A in an immature hematopoietic cell line HMC-1. Biochem Biophys Res Commun 2010; 391: 1028-1032.
19. Wich LG, Ma MW, Price LS, et al. Impact of socioeconomic status and sociodemographic factors on melanoma presentation among ethnic minorities. J Commun Health 2011; 36: 461-468.
20. Brown JE, Brown RF, Miller RM, et al. Coping with metastatic melanoma. Psychooncology 2000; 9: 283-292.
21. Junker N, Thor Straten P, Andersen MH, et al. Characterization of ex vivo expanded tumor infiltrating lymphocytes from patients with malignant melanoma for clinical application. J Skin Cancer 2011; 2011: 1-6.
22. Ullrich SE, Nghiem DX, Khaskina P,. Suppression of an established immune response by UVA-a critical role for mast cells. Photochem Photobiol 2007; 83: 1095-100.
23. Grimbaldeston MA, Nakae S, Kalesnikoff J, et al. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007; 8: 1095-104.
24. Lu LF, Lind EF, Gondek DC, et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006; 442: 997-1002.
25. Jeong HJ, Lee SA, Moon PD, et al. Alginic acid has anti-anaphylactic effects and inhibits inflammatory cytokine expression via suppression of nuclear factor-kappaB activation. Clin Exp Allergy 2006; 36: 785-794.
26. Galli SJ, Dvorak AM, Dvorak HF,. Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function. Prog Allergy 1984; 34: 1-141.
27. Blair RJ, Meng H, Marchese MJ, et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997; 99: 2691-2700.
28. Ribatti D, Crivellato E,. Mast cells, angiogenesis and cancer. Adv Exp Med Biol 2001; 716: 270-288.
29. Ghosh AK, Hirasawa N, Ohtsu H, et al. Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice. J Exp Med 2002; 195: 973-982.
30. Dvorak HF, Galli SJ, Dvorak AM,. Cellular and vascular manifestations of cell-mediated immunity. Hum Pathol 1986; 17: 122-137.
31. Isaji M, Miyata H, Ajisawa Y, et al. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br J Pharmacol 1997; 122: 1061-1066.
32. De Luisi A, Mangialardi G, Ria R, et al. Anti-angiogenic activity of carebastine: a plausible mechanism affecting airway remodelling. Eur Respir J 2009; 34: 958-966.
33. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004; 10: 858-864.
34. Forsythe JA, Jiang BH, Iyer NV, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 1996; 16: 4604-4613.
35. Kelly BD, Hackett SF, Hirota K, et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 2003; 93: 1074-1081.
36. Simon MP, Tournaire R, Pouyssegur J,. The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1. J Cell Physiol 2008; 217: 809-818.
37. Manalo DJ, Rowan A, Lavoie T, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. Blood 2005; 105: 659-669.
38. Bosch-Marce M, Okuyama H, Wesley JB, et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 2007; 101: 1310-8.
39. Hiromatsu Y, Toda S,. Mast cells and angiogenesis. Microsc Res Tech 2003; 60: 64-69.
40. Maltby S, Freeman S, Gold MJ, et al. Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration. PLoS One 2011; 6: e18160.